Rationale of the growth failure in children with renal diseases study

The Journal of Pediatrics

Volumn 116, Issue 2, 1990, Pages

  Chan, James C M ^{a,b,c,d,e,f,g}   Greifer, Ira ^{a,b,c,d,e,f,g}   Boineau, Frank G ^{a,b,c,d,e,f,g}   Mendoza, Stanley A ^{a,b,c,d,e,f,g}   McEnery, Paul T ^{a,b,c,d,e,f,g}   Strife, C Frederic ^{a,b,c,d,e,f,g}   Abitbol, Carolyn L ^{a,b,c,d,e,f,g}   Stapleton, F Bruder ^{a,b,c,d,e,f,g}   Roy III, Shane ^{a,b,c,d,e,f,g}   Strauss, Jose ^{a,b,c,d,e,f,g}  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d TULANE UNIVERSITY   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^f LE BONHEUR CHILDREN S HOSPITAL   (United States)

^g UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL STUDY; FUTUROLOGY; GROWTH DISORDER; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MINERAL METABOLISM; NUTRITION; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PRIORITY JOURNAL; PROTEIN METABOLISM; REVIEW;

CALCITRIOL; CHILD; ENERGY METABOLISM; GROWTH DISORDERS; HUMAN; KIDNEY FAILURE, CHRONIC; NUTRITIONAL STATUS; PROTEINS; RANDOMIZED CONTROLLED TRIALS;

EID: 0025174018     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(05)82917-8     Document Type: Article

References (86)

1. Increased growth after long-term oral 1-α-25-vitamin D in childhood renal osteodystrophy
2. 3
3. 3 on renal function, mineral balance and growth of children with severe chronic renal disease
4. A simple method of estimating progression of chronic renal failure
5. Chronic progressive renal disease: rate of change of serum creatinine concentration
6. The progression of end-stage kidney disease in children: effect of dietary therapy
7. Essential amino acids and their nitrogen-free analogues in the treatment of chronic renal failure
8. Progression of renal insufficiency in pediatric patients: estimation from serum creatinine
9. 3 in childhood renal osteodystrophy
10. Clinical disorders of calcium metabolism in chronic renal failure in children
11. 3
12. Controlled trial of 1-α-hydroxycholecalciferol in chronic renal failure
13. Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol
14. 3 in nondialysis chronic renal failure: a controlled therapeutic trial
15. Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D, in uremic man
16. 3 in chronic renal failure: a potent analog of the kidney hormone, 1,25-dihydroxycholecalciferol
17. 3 in children with renal osteodystrophy associated with hemodialysis
18. 3 on growth and mineral metabolism
19. 3
20. Studies of calcium and phosphorus metabolism with special reference to pathogenesis and effects of dihydrotachysterol (AT 10) and iron
21. Vitamin-D: metabolism and function
22. Unique biosynthesis by kidney of a biologically active vitamin D metabolite
23. 3
24. 3 in management of renal osteodystrophy
25. 3 metabolism
26. 3 in renal osteodystrophy
27. Calcium and parathyroid disorders in children: chronic renal failure and treatment with calcitriol
28. Complications of long-term hemodialysis in children: clinical aspects and some measurable variables concerning parathyroid hormone, divalent ions, acid-base metabolism, anemia, nutrition, growth and survival data
29. Metabolic studies of low protein diets in uremia. II. Calcium, phosphorus and magnesium
30. Intestinal absorption of calcium
31. 3
32. Parathyroid function in uremic children with and without osteodystrophy
33. 3 in man
34. 24,25-Dihydroxyvitamin D is a metabolite of vitamin D essential for bone formation
35. 3 on bone
36. Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal man
37. Use of a new phosphate binder in chronic renal insufficiency
38. Phosphate-binding effects of sucralfate in patients with chronic renal failure
39. Magnesium and metabolism in chronic renal failure
40. 3 on jejunal absorption of magnesium in patients with chronic renal disease
41. Iatrogenic magnesium intoxication during 1-α-hydroxycholecalciferol treatment
42. A conspectus of research on zinc requirements in man
43. Reversal of uraemic impotence by zinc
44. Effect of cholecalciferol and 1,25-dihydroxycholecalciferol on the intestinal absorption of zinc in the chick
45. Albumin transferrin and the thyroxine-binding prealbumin/retinol-binding protein complex in assessment of malnutrition
46. The effects of diseases of the liver, thyroid, and kidneys on the transport of vitamin D in human plasma
47. Serum proteins as indicators of poor dietary intake in patients with chronic renal failure
48. Biochemical assessment of protein-calorie malnutrition
49. Complement activity in children with protein-calorie malnutrition
50. Methods for assessing nutritional status of patients with renal failure
51. Biochemical assessment of the nutritional status of low-income pregnant women of Mexican descent
52. The insertion tape: a new circumference tape for use in nutritional assessment
53. Growth assessment in abnormal children
54. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty
55. Protein and amino acid metabolism in uremic patients undergoing maintenance hemodialysis
56. Abnormal amino acid and protein metabolism in uremia
57. Effect of uremia on nutritionally induced variations in protein metabolism
58. Principles of essential amino acid therapy in uremia
59. Intracellular free amino acids in muscle tissue of patients with chronic uremia: effect of peritoneal dialysis and infusion of essential amino acids
60. Glucose intolerance in uremia: quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin
61. Abnormal carbohydrate metabolism in chronic renal failure: the potential role of accelerated glucose production, increased gluconeogenesis, and impaired glucose disposal
62. Amino acid metabolism in patients with advanced uremia and in patients undergoing chronic dialysis
63. Nutritional therapy in children with chronic renal failure
64. Plasma amino acids in children on hemodialysis
65. A study of individual children's diets
66. Growth pattern and dietary intake of children with chronic renal insufficiency
67. Relation of calorie deficiency to growth failure in children on hemodialysis and the growth response to calorie supplementation
68. Energy balance during recovery from malnutrition
69. Total parenteral nutrition in anuric children
70. A rat model for the study of growth failure in uraemia
71. Effect of vitamin D on growth in experimental uraemia
72. Nutrition in renal disease
73. Growth and nutrition of uremic piglets
74. Improved growth in growth-retarded uremic rats with use of calorie supplementation
75. Energy balance and growth: experience in treating children with malnutrition
76. Oral essential amino acid supplements in children with advanced chronic renal failure
77. The mechanism of action of growth hormone on vitamin D metabolism in rats
78. Differential effects of vitamin D (VD) analogue supplementation in experimental uremia
79. 3
80. Stimulation of intestinal mucosal proliferation by vitamin D
81. Studies on the mechanism of action of calciferol. V. Turnover time of chick intestinal epithelial cells in relation to the intestinal action of vitamin D
82. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients
83. 3 on circulating parathyroid hormone in acute renal failure
84. Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cell
85. 3 in the parathyroid glands of patients with renal failure